Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply.
Tahata Y, Sakamori R, Yamada R, Kodama T, Hikita H, Hagiwara H, Imai Y, Hiramatsu N, Tamura S, Yamamoto K, Oshita M, Ohkawa K, Hijioka T, Fukui H, Ito T, Doi Y, Yamada Y, Yakushijin T, Yoshida Y, Tatsumi T, Takehara T; Osaka Liver Forum.
Tahata Y, et al. Among authors: hijioka t.
Aliment Pharmacol Ther. 2022 Jan;55(2):258-259. doi: 10.1111/apt.16721.
Aliment Pharmacol Ther. 2022.
PMID: 34970764
No abstract available.